E-LIB Suche - Ergebnisse für: Hardy-Bessard, A.C.

1

Prognostic value of EndoPredict test in patients with hormo..:

Penault-Llorca, F. ; Dalenc, F. ; Chabaud, S....
ESMO Open. 9 (2024) 5 - p. 103443 , 2024

Link: https://doi.org/10.1016/..

2

Preponderant impact of the chemosensitivity assessed by the..:

You, B. ; Tod, M. ; Leary, A....
Gynecologic Oncology. 159 (2020) - p. 339-340 , 2020

Link: https://doi.org/10.1016/..

3

Need for risk-adapted therapy for malignant ovarian germ ce..:

Derquin, F. ; Floquet, A. ; Hardy-Bessard, A.C....
Gynecologic Oncology. 158 (2020) 3 - p. 666-672 , 2020

Link: https://doi.org/10.1016/..

4

Cetuximab, topotecan and cisplatin for the treatment of adv..:

Kurtz, J.E. ; Hardy-Bessard, A.-C. ; Deslandres, M....
Gynecologic Oncology. 113 (2009) 1 - p. 16-20 , 2009

Link: https://doi.org/10.1016/..

5

5193 Can adjuvant homeopathy improve the control of post-ch..:

Ray-Coquard, I. ; Provençal, J. ; Hardy-Bessard, A.C....
European Journal of Cancer Supplements. 7 (2009) 2 - p. 317-318 , 2009

Link: https://doi.org/10.1016/..

6

P32 Prognostic parameters in node negative breast cancer re..:

Hardy-Bessard, A.C. ; De Roquancourt, A. ; Cottu, P.H....
European Journal of Cancer. 34 (1998) - p. S22 , 1998

Link: https://doi.org/10.1016/..

7

6-day continuous infusion of high-dose ifosfamide with bone..:

Brain, E. C. G. ; Mita, A. ; Soulié, P....
Journal of Cancer Research and Clinical Oncology. 123 (1997) 4 - p. 227-231 , 1997

Link: https://doi.org/10.1007/..

8

41MO ESR1 mutation in untreated endometrial cancer: Prevale..:

Blanc-Durand, F. ; Nikolaev, S. ; Leman, R....
ESMO Open. 9 (2024) - p. 103541 , 2024

Link: https://doi.org/10.1016/..

9

32O 5-year (y) overall survival (OS) with maintenance olapa..:

Lorusso, D. ; Mouret-Reynier, M-A. ; Harter, P....
ESMO Open. 8 (2023) 1 - p. 100812 , 2023

Link: https://doi.org/10.1016/..

10

Vaccination contre la COVID-19 des patients atteints de can..:

Tougeron, D ; Seitz-Polski, B ; Hentzien, M...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.bulcan.2021.03.009. , 2021

Link: https://serval.unil.ch/n..

11

Risk factors for Coronavirus Disease 2019 (COVID-19) severi..:

Lièvre, A ; Turpin, A ; Ray-Coquard, I...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.ejca.2020.09.035. , 2020

Link: https://serval.unil.ch/n..

12

Need for risk-adapted therapy for malignant ovarian germ ce..:

Derquin, F ; Floquet, A ; Hardy-Bessard, A.C...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.ygyno.2020.06.491. , 2020

Link: https://hal.science/hal-..

13

Need for risk-adapted therapy for malignant ovarian germ ce..:

Derquin, F ; Floquet, A ; Hardy-Bessard, A.C...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.ygyno.2020.06.491. , 2020

Link: https://hal.science/hal-..

14

Need for risk-adapted therapy for malignant ovarian germ ce..:

Derquin, F ; Floquet, A ; Hardy-Bessard, A.C...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.ygyno.2020.06.491. , 2020

Link: https://hal.science/hal-..

15

Need for risk-adapted therapy for malignant ovarian germ ce..:

Derquin, F ; Floquet, A ; Hardy-Bessard, A.C...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.ygyno.2020.06.491. , 2020

Link: https://hal.science/hal-..